Level Bio AB (publ) (NGM:LEVBIO)
0.446
+0.016 (3.72%)
At close: Mar 6, 2026
28.16% (1Y)
| Market Cap | 30.51M |
| Revenue (ttm) | 32.36M |
| Net Income (ttm) | -3.54M |
| Shares Out | 68.40M |
| EPS (ttm) | -0.05 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 137,130 |
| Average Volume | 52,723 |
| Open | n/a |
| Previous Close | 0.430 |
| Day's Range | n/a |
| 52-Week Range | 0.264 - 0.450 |
| Beta | 1.16 |
| RSI | 63.11 |
| Earnings Date | Feb 20, 2026 |